Preclinical results of a prosthetic, early-stick graft with functional endothelium

Journal of Vascular Access

Volumn 12, Issue 3, 2011, Pages 231-238

  Hashi, Craig K ^a   Glickman, Marc H ^b  

^a Santa Ana Bio   (United States)

^b Vascular and Transplant Specialists P C   (United States)

Author keywords

Arteriovenous; Bypass graft; Synthetic access graft; Vascular graft

Indexed keywords

NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL GRAFT; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM; GRAFT PATENCY; HISTOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFORMATION PROCESSING; INTERMETHOD COMPARISON; NONHUMAN; POLITEF IMPLANT; VASCULAR ACCESS; WOUND HEALING;

EID: 80052989825     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/JVA.2010.6048     Document Type: Article

References (16)

1. US Renal Data System. USRDS 2008 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008.
2. US Renal Data System. USRDS 2007 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
3. National Kidney Foundation. NFK-K/DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 1997; 9: 32-3.
4. National Kidney Foundation. NFK-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis 2001; 37: 5137-81.
5. Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008; 299: 2164-71.
6. Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2001; 34: 694-700.
7. Huber TS, Buhler AG, Seeger JM. Evidence-based data for the hemodialysis access surgeon. Semin Dial 2004; 17: 217-23.
8. Dixon BS, Beck GJ, Vazquez MA, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 2009; 360: 2191-201.
9. Hashi CK, Derugin N, Janairo RR, et al. Antithrombogenic modification ofsmall-diameter microfibrous vascular grafts. Arterioscler Thromb Vasc Biol 2010; 30: 1621-7.
10. International Organization for Standardization. ISO 11135:1:2007 sterilization of health care products: ethylene oxide: Part 1: requirements for development, validation and routine control of a sterilization process for medical devices. Available at: http://www.iso.org/iso/catalogue_detail. htm?csnumber=43185. Accessed 4 October 2010.
11. International Organization for Standardization. ISO 10993-3:2003 biological evaluation of medical devices: Part 3: tests for genotoxicity, carcinogenicity and reproductive toxicity. Available at: http://www.iso.org/iso/iso-catalogue/catalogue-tc/catalogue detail.htm?csnumber=32162. Accessed 4 October 201-0.
12. International Organization for Standardization. ANSI/AAMI/ISO 7198:1998 cardiovascular implants: tubular vascular prostheses. Available at: http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detai I.htm?csnumber=25374. Accessed 4 October 2010.
13. Maxwell AJ, Niebauer J, Lin PS, Tsao PS, Bernstein D, Cooke JP. Hypercholesterolemia impairs exercise capacity in mice. Vasc Med 2009; 14: 249-57.
14. Kundu S. Central venous disease in hemodialysis patients: prevalence, etiology and treatment. J Vasc Access 2010; 11: 1-7.
15. Berardinelli L. Graft and graft materials as vascular substitutes for haemodialysis access construction. Eur J Vasc Endovasc Surg 2006; 32: 203-11.
16. Scher LA, Katzman HE. Alternative graft materials for hemodialysis access. Semin Vasc Surg 2004; 17: 19-24.